(-)-gallocatechin gallate has been researched along with Herpes Simplex in 1 studies
*Herpes Simplex: A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corbo, C; Di Maggio, V; Hillier, S; Isaacs, CE; Jenkins, EC; Jia, JH; Rohan, L; Wen, GY; Xu, W | 1 |
1 other study(ies) available for (-)-gallocatechin gallate and Herpes Simplex
| Article | Year |
|---|---|
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
Topics: Animals; Catechin; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Female; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Microscopy, Electron; Vero Cells; Virion; Virus Inactivation | 2008 |